# WaveTec Vision Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wavetec-vision-systems

- Industry: Biotechnology
- Headquarters: Aliso Viejo, US
- Website: www.wavetecvision.com
- Total disclosed funding: $61M
- Latest round: Series D (Jun 10, 2013)
- Investors on record: 7

## About

WaveTec Vision Systems is a technology company focused on developing advanced solutions that enhance operational efficiency and user experience, particularly in healthcare and logistics sectors.WaveTec Vision Systems operates from Aliso Viejo, US, specializing in innovative software solutions. The company has conducted a total of 9 deals, with the most recent deal occurring on August 27, 2014, when Alcon agreed to acquire WaveTec Vision for USD 11.00 mn. The firm has raised a total amount of USD 11.00 mn through its LATEST ROUND, which was Series D.The company specializes in a range of innovative solutions designed to address specific industry challenges, primarily focusing on streamlining operational efficiencies and enhancing user experiences. Their core offerings include advanced software platforms that integrate seamlessly with existing systems, enabling businesses to optimize their workflows and improve data management. These products are particularly geared towards sectors such as healthcare, finance, and logistics, where timely data access and reliability are critical. The company also provides tailored consulting services that guide clients in implementing these solutions effectively. Their client base spans multiple geographical markets, including North America, Europe, and Asia, where they serve a diverse group of end users, from small enterprises to large multinational corporations.The company generates revenue through a structured model that encompasses both subscription-based services and direct sales of its flagship software products. Clients typically engage with the firm via annual subscriptions that provide access to the latest software updates and customer support, ensuring they remain competitive in their respective sectors. Additionally, the company collaborates with various partners, facilitating sales through established distributors and resellers in targeted regions. Specific pricing plans are aligned with the features and scale of deployment required by the clients, with options tailored to meet the needs of both small businesses and large organizations. This multi-faceted approach to transactions underscores the company’s commitment to delivering value across different market segments while maintaining strong client relationships.WaveTec Vision Systems is focused on launching new products aimed at enhancing their service offerings, with specific timelines for release yet to be announced. The company plans to expand into new geographic markets, particularly targeting additional regions in Asia and Europe by the end of 2025. Recent funding, raised in Series D, will be utilized to support these initiatives, ensuring that the company can effectively implement its growth strategy following the acquisition by Alcon.

## Funding rounds

- Series D, Jun 10, 2013, $7M — Burrill & Company, Versant Ventures, De Novo Ventures, Accuitive Medical Ventures, Foresite Capital
- Series D, May 28, 2013, $2M — Burrill & Company, Versant Ventures, De Novo Ventures, Accuitive Medical Ventures, Foresite Capital
- Series D, Feb 8, 2013, $2M — Burrill & Company, Versant Ventures, De Novo Ventures, Accuitive Medical Ventures, Foresite Capital
- Series D, Mar 26, 2012, $17M — Versant Ventures, De Novo Ventures, Accuitive Medical Ventures, Gund Investment Corporation, Biomark Capital
- Series C, Feb 1, 2009, $20M — Versant Ventures, De Novo Ventures, Accuitive Medical Ventures
- Series C, May 18, 2007, $13M — Versant Ventures, De Novo Ventures, Accuitive Medical Ventures

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series C, Series D
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series C, Series D
- Accuitive Medical Ventures (https://capitalatlas.ai/funds/accuitive-medical-ventures) — Series C, Series D
- Gund Investment Corporation — Series D
- Biomark Capital (https://capitalatlas.ai/funds/biomark-capital) — Series D
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series D
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series D